Skip to content
This GLP
By This GLP Editorial Team · Updated September 2026First months only, rate behind the intake

Society of You review

Both injection cards lead with a first-month figure, and the standing rate is shown only after contact details are entered.

The verdict

Society of You shows $149 and $249 as first-month figures for injected semaglutide and tirzepatide. The standing rate is not published before the intake. This site ranks no price for either line.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection · Oral
Prescription
Required
Compounded
Yes — not FDA-approved

Society of You sells compounded semaglutide and compounded tirzepatide, both as weekly injections. Its one oral card is metformin, which is not a GLP-1.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages price products rather than describing the clinician behind them.

    The intake's first step asks for a name, email and phone number. The monthly rate comes after that step. The refund policy refers to introductory pricing.

  2. What happens when the dose goes up?

    Nothing published says what either line does at a higher dose. No milligram appears on any card.

  3. What the price includes

    A first-month figure is not a price. This site ranks a seller on the rate a buyer pays from month two. That rate is not shown before the intake, so both rows carry no figure.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them, and no agency reviews a compounded preparation before dispensing.

Where it holds up, and where it does not

  • Strength: Semaglutide and tirzepatide from one seller
  • Strength: Both are weekly injections
  • Strength: The first-month figures are shown on the cards
  • Limitation: No standing rate is published
  • Limitation: Contact details come before the monthly price
  • Limitation: No milligram appears on any line
  • Limitation: Nothing lists the states served

What the evidence says about this kind of treatment

The assessment above is about Society of You. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader willing to enter contact details before seeing the monthly rate.
Wrong for
A reader budgeting past month one from the opening figure.

The evidence behind what Society of You prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How Society of You compares

SellerWho it suitsGo
BioverseReaders who want semaglutide cheaply and ignore the struck figure beside itSee Bioverse →
Bionomy HealthReaders who want to be able to stop by doing nothingSee Bionomy Health →
Bodi EnviPatients who value named care partners and can monitor refill noticesSee Bodi Envi →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: VitaFusions IVVital EdgeVitalex HealthVitara RXVitaStirVoxy

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Is there a tirzepatide tablet?
No. Tirzepatide is sold by injection only, and the one oral card is not a GLP-1.
What does month two cost?
The site does not say before the intake. The $149 and $249 on the cards are first months.
Why does this site show no price?
It ranks the rate a buyer pays after month one. Society of You does not publish that rate before collecting contact details.
This GLP Editorial TeamPublisher · Updated September 2026

How this was assessed. The four questions above are answered from Society of You’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.